Folic acid supplementation for the prevention of neural tube defects US preventive services task force recommendation statement

JAMA - Journal of the American Medical Association

Volumn 317, Issue 2, 2017, Pages 183-189

  Bibbins Domingo, Kirsten ^a   Grossman, David C ^b   Curry, Susan J ^c   Davidson, Karina W ^d   Epling, John W ^e   Garcia, Francisco A R ^f   Kemper, Alex R ^g   Krist, Alex H ^h,i   Kurth, Ann E ^j   Landefeld, C Seth ^k   Mangione, Carol M ^l   Phillips, William R ^m   Phipps, Maureen G ⁿ   Pignone, Michael P ^o   Silverstein, Michael ^p   Tseng, Chien Wen ^q  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f Pima County Health Department   (United States)

^g DUKE UNIVERSITY   (United States)

^h Fairfax Family Practice Residency   (United States)

ⁱ VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^j YALE UNIVERSITY   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF WASHINGTON   (United States)

ⁿ BROWN UNIVERSITY   (United States)

^o UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^p BOSTON UNIVERSITY   (United States)

^q UNIVERSITY OF HAWAII   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN B COMPLEX;

CLINICAL EFFECTIVENESS; EVIDENCE BASED MEDICINE; HEALTH SERVICE; HUMAN; NEURAL TUBE DEFECT; PREGNANCY; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; UNITED STATES; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; ADVISORY COMMITTEE; DIETARY REFERENCE INTAKE; DIETARY SUPPLEMENT; FEMALE; NEURAL TUBE DEFECTS;

ADVISORY COMMITTEES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; RECOMMENDED DIETARY ALLOWANCES; RISK ASSESSMENT; UNITED STATES; VITAMIN B COMPLEX;

EID: 85010526693     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.19438     Document Type: Review

References (33)

1. Viswanathan M, Treiman KA, Kish-Doto J, Middleton JC, Coker-Schwimmer EJL, Nicholson WK. Folic Acid Supplementation: An Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 145. Rockville, MD: Agency for Healthcare Research and Quality; 2017. AHRQ publication 14-05214-EF-1.
2. Williams J, Mai CT, Mulinare J, et al; Centers for Disease Control and Prevention. Updated estimates of neural tube defects prevented by mandatory folic acid fortification-United States, 1995-2011. MMWR Morb Mortal Wkly Rep. 2015;64(1):1-5.
3. Viswanathan M, Treiman KA, Kish-Doto J, Middleton JC, Coker-Schwimmer EJ, Nicholson WK. Folic acid supplementation for the prevention of neural tube defects: An updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016 .19193
4. Tinker SC, Cogswell ME, Devine O, Berry RJ. Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med. 2010;38(5): 534-542.
5. Bentley TG, WillettWC, Weinstein MC, Kuntz KM. Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am J Public Health. 2006;96(11): 2040-2047.
6. Finer LB, Zolna MR. Unintended pregnancy in the United States: Incidence and disparities, 2006. Contraception. 2011;84(5):478-485.
7. Wolff T, Witkop CT, Miller T, Syed SB. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Update of the Evidence for the US Preventive Services Task Force: Evidence Synthesis No. 70. Rockville, MD: Agency for Healthcare Research and Quality; 2009. AHRQ publication 09-051132-EF-1.
8. US Preventive Services Task Force. Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(9):626-631.
9. Tinker SC, Hamner HC, Qi YP, Crider KS. U.S. women of childbearing age who are at possible increased risk of a neural tube defect-affected pregnancy due to suboptimal red blood cell folate concentrations, National Health and Nutrition Examination Survey 2007 to 2012. Birth Defects Res A Clin Mol Teratol. 2015;103(6):517-526.
10. Institute of Medicine Food and Nutrition Board. Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline.Washington, DC: National Academies Press; 1998.
11. Dietary Guidelines Advisory Committee; Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Advisory Report to the Secretary of Health and Human Services. Rockville, MD: US Department of Health and Human Services and US Department of Agriculture; 2015.
12. National Institutes of Health, Office of Dietary Supplements. Folate: Dietary supplement fact sheet. https://ods.od.nih.gov/factsheets/Folate -HealthProfessional/. 2016. Accessed November 22, 2016.
13. Community Preventive Services Task Force. Birth defects: Community-wide campaigns to promote the use of folic acid supplements. https://www.thecommunityguide.org/findings /birth-defects-community-wide-campaigns -promote-use-folic-acid-supplements. 2004. Accessed November 22, 2016.
14. US Food and Drug Administration. FDA approves folic acid fortification of corn masa flour. http://www.fda.gov/NewsEvents/Newsroom /PressAnnouncements/ucm496104.htm. April 14, 2016. Accessed November 22, 2016.
15. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327(26):1832-1835.
16. Czeizel AE, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol. 2004;70(11):853-861.
17. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262(20):2847-2852.
18. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6(3):219-226.
19. Ahrens K, Yazdy MM, Mitchell AA, Werler MM. Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology. 2011; 22(5):731-737.
20. Mosley BS, ClevesMA, Siega-Riz AM, et al; National Birth Defects Prevention Study. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol. 2009;169(1): 9-17.
21. Czeizel AE, Metneki J, Dudas I. The higher rate of multiple births after periconceptional multivitamin supplementation: An analysis of causes. Acta Genet Med Gemellol (Roma). 1994;43 (3-4):175-184.
22. Vollset SE, Gjessing HK, Tandberg A, et al. Folate supplementation and twin pregnancies. Epidemiology. 2005;16(2):201-205.
23. Crider KS, Cordero AM, Qi YP, Mulinare J, Dowling NF, Berry RJ. Prenatal folic acid and risk of asthma in children: A systematic review and meta-analysis. Am J Clin Nutr. 2013;98(5):1272-1281.
24. Yang L, Jiang L, BiM, et al. High dose of maternal folic acid supplementation is associated to infant asthma. Food Chem Toxicol. 2015;75:88-93.
25. Tsang BL, Devine OJ, Cordero AM, et al. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: A systematic review and meta-analysis of trials and observational studies. Am J Clin Nutr. 2015;101(6):1286-1294.
26. Cheschier N; ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: neural tube defects. number 44, July 2003 (replaces committee opinion number 252, March 2001). Int J Gynaecol Obstet. 2003;83(1):123-133.
27. American Academy of Family Physicians. Clinical Preventive Service Recommendation: neural tube defects. http://www.aafp.org/patient -care/clinical-recommendations/all/neural-tube -defects.html. Accessed November 22, 2016.
28. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41(RR-14):1-7.
29. American Academy of Pediatrics Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics. 1999;104(2, pt 1):325-327.
30. Harden CL, Pennell PB, Koppel BS, et al; American Academy of Neurology; American Epilepsy Society. Practice parameter update: Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):142-149.
31. Toriello HV; Policy and Practice Guideline Committee of the American College of Medical Genetics. Policy statement on folic acid and neural tube defects. Genet Med. 2011;13(6):593-596.
32. American College of Obstetricians and Gynecologists. ACOG committee opinion number 313, September 2005: The importance of preconception care in the continuum of women's health care. Obstet Gynecol. 2005;106(3):665-666.
33. Centers for Disease Control (CDC). Use of folic acid for prevention of spina bifida and other neural tube defects-1983-1991. MMWR Morb Mortal Wkly Rep. 1991;40(30):513-516.